HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Assets per Share

The Total Assets per Share of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 3, 2026 is 21,267.66 VND. In the previous year, Total Assets per Share was 20,295.63 VND — a change of 4.79% (higher).

Assets per Share

21,267.66VND

YoY

4.79%

Last updated:

Total Assets per Share of HaTay Pharmaceutical JSC is 2024 21,267.66 VND. Total Assets per Share of HaTay Pharmaceutical JSC was 2023 20,295.63 VND. It decreases by 4.79% higher compared to the previous year.

The HaTay Pharmaceutical JSC Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2017
7,007.60 VND
Jan 1, 2018
7,056.34 VND
Jan 1, 2019
8,150.43 VND
Jan 1, 2020
10,157.91 VND
Jan 1, 2021
13,663.80 VND
Jan 1, 2022
16,224.26 VND
Jan 1, 2023
20,295.63 VND
Jan 1, 2024
21,267.66 VND
The HaTay Pharmaceutical JSC Assets per Share history
YEARAssets per ShareYoY
21,267.66VND+4.79%
20,295.63VND+25.09%
16,224.26VND+18.74%
13,663.80VND+34.51%
10,157.91VND+24.63%
8,150.43VND+15.51%
7,056.34VND+0.70%
7,007.60VND+23.49%
5,674.53VND+17.73%
4,819.96VND+21.25%
3,975.33VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Total Assets per Share of HaTay Pharmaceutical JSC is 21,267.66 VND in 2024.

Total Assets per Share of HaTay Pharmaceutical JSC changed from 20,295.63 VND to 21,267.66 VND, representing a 4.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — HaTay Pharmaceutical JSC

All Key Metrics — HaTay Pharmaceutical JSC